skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
15449353
Filing Dt:
03/03/2017
Publication #:
Pub Dt:
06/22/2017
Inventors:
Julie Kay Cahill, Michael Karl Bechtold, Katja Maren Fastnacht, Kieran James Lennon et al
Title:
IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE
Assignment: 1
Reel/Frame:
041616/0321Recorded: 03/17/2017Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
10/05/2009
Exec Dt:
10/05/2009
Exec Dt:
10/05/2009
Exec Dt:
10/05/2009
Exec Dt:
10/05/2009
Assignee:
MAX-PLANCK-RING 2
65205 WIESBADEN
LUDWIGSHAFEN, GERMANY 67061
Correspondent:
ASTRAZENECA PHARMACEUTICALS
ONE MEDIMMUNE WAY
GAITHERSBURG, MD 20878
Assignment: 2
Reel/Frame:
041618/0027Recorded: 03/17/2017Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
10/23/2009
Exec Dt:
10/23/2009
Assignee:
15 STANHOPE GATE
LONDON, ENGLAND W1K 1LN
Correspondent:
ASTRAZENECA PHARMACEUTICALS
ONE MEDIMMUNE WAY
GAITHERSBURG, MD 20878
Assignment: 3
Reel/Frame:
041618/0175Recorded: 03/17/2017Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
03/11/2011
Assignee:
2 KINGDOM STREET
LONDON, ENGLAND W2 6BD
Correspondent:
ASTRAZENECA PHARMACEUTICALS
ONE MEDIMMUNE WAY
GAITHERSBURG, MD 20878

Search Results as of: 06/20/2024 03:13 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT